Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11697689
SERIAL NO

16466769

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed is a method for delivery of an anti-cancer agent into a cell expressing the OAcGD2 ganglioside by using an antibody recognizing the OAcGD2 ganglioside.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • OGD2 PHARMA; NANTES UNIVERSITÉ; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); INSTITUT DE CANCEROLOGIE DE L'OUEST

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Assouline, Brigitte Courbevoie, FR 9 69
Birkle, Stéphane Nantes, FR 3 20
Cochonneau, Denis Coueron, FR 5 5
Faraj, Sébastien Nantes, FR 2 0
Fleurence, Julien Nantes, FR 2 0
Le, Doussal Jean-Marc Lausanne, CH 15 127
Terme, Mickaël Nantes, FR 4 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 11, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 11, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 11, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00